Humana (HUM) Price Target Increased to $410.00 by Analysts at Jefferies Financial Group

Humana (NYSE:HUM) had its price target hoisted by stock analysts at Jefferies Financial Group to $410.00 in a research report issued on Thursday, The Fly reports. The brokerage presently has a “buy” rating on the insurance provider’s stock. Jefferies Financial Group’s price target would suggest a potential upside of 15.83% from the company’s previous close.

A number of other brokerages have also issued reports on HUM. MED reiterated an “outperform” rating and set a $373.00 price target (up previously from $350.00) on shares of Humana in a research report on Thursday. Cowen began coverage on Humana in a research report on Monday, September 17th. They set a “market perform” rating and a $372.00 price target for the company. SunTrust Banks boosted their price target on Humana to $380.00 and gave the stock a “hold” rating in a research report on Wednesday, September 19th. Credit Suisse Group boosted their price target on Humana from $350.00 to $370.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Finally, Argus boosted their price target on Humana to $375.00 and gave the stock a “buy” rating in a research report on Tuesday, September 4th. Seven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $343.35.

Shares of HUM stock opened at $353.98 on Thursday. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.47. Humana has a 1 year low of $231.90 and a 1 year high of $355.88. The firm has a market cap of $45.71 billion, a price-to-earnings ratio of 30.23, a price-to-earnings-growth ratio of 1.65 and a beta of 1.03.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 7th. The insurance provider reported $4.58 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.29 by $0.29. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same quarter last year, the firm posted $3.39 earnings per share. Equities analysts expect that Humana will post 14.18 EPS for the current year.

In other news, CEO Bruce D. Broussard sold 18,000 shares of the company’s stock in a transaction on Monday, September 10th. The stock was sold at an average price of $328.66, for a total value of $5,915,880.00. Following the completion of the sale, the chief executive officer now owns 71,085 shares in the company, valued at $23,362,796.10. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Elizabeth D. Bierbower sold 3,092 shares of the company’s stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $330.00, for a total value of $1,020,360.00. Following the completion of the sale, the insider now owns 14,289 shares of the company’s stock, valued at approximately $4,715,370. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Stratos Wealth Partners LTD. acquired a new stake in shares of Humana during the third quarter worth $108,000. Sun Life Financial INC raised its position in shares of Humana by 120.7% during the second quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock worth $111,000 after purchasing an additional 204 shares during the period. Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Humana by 2,984.6% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 388 shares during the period. Smithfield Trust Co. raised its position in shares of Humana by 531.2% during the third quarter. Smithfield Trust Co. now owns 486 shares of the insurance provider’s stock worth $165,000 after purchasing an additional 409 shares during the period. Finally, Patriot Financial Group Insurance Agency LLC raised its position in shares of Humana by 64.6% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 512 shares of the insurance provider’s stock worth $173,000 after purchasing an additional 201 shares during the period. 92.62% of the stock is currently owned by institutional investors.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Further Reading: Asset Allocation, Balancing Your Investments

The Fly

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply